Skip to main content

Table 1 characteristics of study population at the baseline and end point*

From: Sex specific trajectories of central adiposity, lipid indices, and glucose level with incident hypertension: 12 years Follow-up in Tehran lipid and glucose study

 

Baseline

End point

P Value

Females (n = 2979)

 Age (years)

28.63 (6.60)

42.12 (7.55)

0.00

 Smoking status

  (Current) (%)

0.6

2.3

0.06

  (paste) (%)

2.3

4.1

 

 BMI (kg/m2)

25.24 (4.66)

28.45 (5.10)

0.00

 WC (cm)

80.46 (11.32)

91.34 (11.62)

0.02

 FPG (mg/dL)

87.26 (14.43)

94.01 (21.06)

0.01

 TG (mg/dL)

99 (72–143)

111 (79–157)

0.04

 HDL_C

44.60 (10.30)

50.20 (11.47)

0.02

 TC

180 (157–206)

186 (164–212)

0.05

Males (n = 2051)

 Age (years)

29.22 (6.67)

42.33 (7.58)

0.00

 Smoking status

  (Current) (%)

26.4

29.2

0.06

  (Paste) (%)

9.2

13.1

 

 BMI (kg/m2)

24.87 (4.21)

27.65 (4.18)

0.03

 WC (cm)

85.14 (11.44)

96.48 (10.91)

0.03

 FPG (mg/ dL)

88 (83–94)

96 (87–101)

0.04

 TG (mg/dL)

133 (91–198)

147 (103–206)

0.03

 HDL-C

37.88 (9.05)

41.39 (9.84)

0.03

 TC

182 (159–211)

188 (164–215)

0.05

  1. Data are mean (standard deviation) for continues, and frequency (%) for categorical variables *incident hypertension/or the last follow-up
  2. BMI Body mass index, DBP Diastolic blood pressure, SBP Systolic blood pressure, TG Triglyceride, TC total cholesterol, FPG fasting plasma glucose